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The transcription factor c-Myc is a cellular oncoprotein generally upregulated in most of human
cancers. NF-jB essential modulator (NEMO) caused phosphorylation and stabilization of c-Myc pro-
tein in the nucleus through direct interaction. The interaction caused reduced ubiquitination of c-
Myc by inhibiting ubiquitinating activity of Fbw7 without blocking the interaction between c-Myc
and Fbw7. As a consequence, NEMO enhanced the expression of several selected c-Myc targets. Com-
pared to the classical role as an essential subunit for the activity of IKK complex, stabilization of c-
Myc by direct interaction is a unique function of NEMO, representing a new mechanism to regulate
c-Myc activity.
Structured summary:
MINT-8045088: c-Myc (uniprotkb:P01106) and NEMO (uniprotkb:Q9Y6K9) colocalize (MI:0403) by ﬂuo-
rescence microscopy (MI:0416)
MINT-8045072, MINT-8045101: c-Myc (uniprotkb:P01106) physically interacts (MI:0915) with NEMO
(uniprotkb:Q9Y6K9) by anti tag coimmunoprecipitation (MI:0007)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction c-Myc, and PI3 K-Akt-GSK3, which inhibits phosphorylation atThe cellular oncoprotein c-Myc plays a critical role in multiple
cellular processes including cell cycle progression, proliferation,
differentiation, and apoptosis. The expression of c-Myc is generally
upregulated in most of human cancers during tumor progression
[1]. Tight and proper regulation of c-Myc accumulation, which is
important for tumor growth and development, is achieved by mul-
tiple mechanisms acting at different stages of protein expression
including the regulation of transcription, mRNA stability, transla-
tion, and protein stability [2]. Several mechanisms have been re-
ported to regulate the stability of c-Myc. F-box protein and
ubiquitin ligase Skp2 regulates c-Myc protein stability by promot-
ing ubiquitination of c-Myc [3]. Another F-box protein Fbw7
interacts with c-Myc facilitating its ubiquitination, and thereby
destabilizes c-Myc in a phosphorylation dependent manner [4].
Ras activation stabilizes c-Myc protein through two effector path-
ways; Raf-MEK-ERK, which phosphorylates Ser62 and stabilizeschemical Societies. Published by E
; CHX, cycloheximide; LMB,
; GAPDH, glyceraldehyde-3-
tion Cancer Research, Korea
on-gil, Nowon-gu, Seoul 139-Thr58 by GSK3 and thereby stabilizes c-Myc protein [5]. Cyclin
G1-activated Cdk5 also phopshorylates Ser62 of c-Myc, resulting
in the stabilization of c-Myc [6]. In addition to phosphorylation,
acetylation of c-Myc by CBP, p300, hGCN5/PCAF or TIP60 enhances
transcriptional activity and stability of c-Myc by interfering with
ubiquitination [7–9].
NF-jB essential modulator (NEMO)/IKKc is a regulatory subunit
of IKK complex, which is activated in response to a variety of stim-
uli such as TNF and LPS and plays a critical role in the activation of
NF-jB pathway. Two kinase subunits, IKKa and IKKb, are other
constituents of IKK complex. NEMO itself does not have kinase
activity, but is absolutely required for such a canonical pathway
of NF-jB activation, likely by acting as a scaffold protein in the
IKK complex [10]. Proximal arrangement of IKK complex close to
its upstream kinase complex is required for the activation of IKK
complex. NEMO was suggested to play a critical role in this molec-
ular rearrangement through speciﬁc recognition of K63-linked
polyubiquitin chains of the adaptor molecule RIP1, to which the
upstream kinase complex is also recruited [11]. The action of
NEMO is not restricted to the cytoplasm. It was demonstrated that
genotoxic stress causes nuclear translocation of IKK-unbound free
NEMO via site-speciﬁc sumoylation, allowing subsequent ATM-
dependent ubiquitination of NEMO to activate IKK complex in
the cytoplasm [12]. Besides the cytoplasmic role in the activationlsevier B.V. All rights reserved.
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repressor of NF-jB-dependent gene expression [13].
Several reports have demonstrated that NF-jB signaling and c-
Myc are linked at various levels. NF-jB activation induces c-myc
transcription to support cell growth in B cells [14]. Conversely, c-
Myc potentiates apoptosis by impairing NF-jB activation [15,16].
It has also been reported that c-Myc suppresses the expression of
almost all the components of NF-jB networks including IKKs dur-
ing Myc-induced lymphomagenesis [17]. These observations
prompted us to test the possibility that IKKs may also play a role
in regulating c-Myc. Here, we report a new function of NEMO inde-
pendent of IKK activation. We demonstrate that NEMO induces sta-
bilization and phosphorylation of c-Myc protein through direct
interaction in the nucleus, resulting in enhanced expression of c-
Myc target proteins.2. Materials and methods
2.1. Cell culture and plasmid constructs
HEK293T and HEK293 were grown in DME medium supple-
mented with 10% fetal bovine serum (FBS). H460 and SW480 were
maintained in RPMI 1640 medium supplemented with 10% FBS.
The expression vectors for HA-NEMO, HA-IKKa and HA-IKKb were
provided by Dr. M. Karin (University of California at San Diego,
USA). The c-Myc expression vector and 4E box-luciferase reporter
were obtained from Dr. R. Abraham (The Burnham Institute for
Medical Research, USA), and c-Myc promoter reporter was from
Dr. K. Kinzler (Johns Hopkins University, USA). The expression vec-
tor for HA-Fbw7 was from Dr. K. I. Nakayama (Kyushu University,
Japan). HA-NEMO expressing stable cell line was established by
transfection of HEK293 cells with HA-NEMO expression vector fol-
lowed by selection with G418 at 2 mg/ml.
2.2. Western blot, co-immunoprecipitation assays, and
immunoﬂuorescence microscopy
Western blot analyses and immunoﬂuorescence microscopy
were performed as described elsewhere [18]. Antibodies speciﬁc
for c-Myc (N-262 or 9E10), phospho-c-Myc (Thr58), NEMO (FL-
419), ubiquitin (P4D1), c-glutamyl-cysteine synthetase (c-GCSH)
(H-300), cyclin D1 (HD11), cyclin E (HE111) and HA-epitope (F-7)
were purchased from Santa Cruz Biotechnology. Polyclonal phos-
pho (Ser62)-c-MYC (ab39217) antibody was from Abcam. For co-
immunoprecipitation assay, HEK293T cells transfected with c-
Myc and HA-NEMO expression vectors were washed twice with
PBS and cross-linked by incubating the cells in 1 mM Dithio-bis
(succinimidyl propionate) for 15 min at room temperature. Cross-
linking reaction was quenched by adding Tris–HCl (pH 7.6) to
10 mM and incubating for 15 min. After washing three times with
cold PBS, cells were lysed in P-RIPA buffer (1% NP-40, 0.5% deoxy-
cholic acid, 0.1% SDS, 10 mM EDTA in PBS) containing protease
inhibitors. Lysate was incubated with anti-HA antibody and protein
A/G-sepharose. After extensive washing with P-RIPA buffer, beads
were boiled in loading buffer and analyzed by Western blotting.
2.3. RT-PCR and qRT-PCR
Total RNAs were extracted using Trizol reagent. Two micro-
grams of total RNAs were transcribed into single-stranded cDNA
using Superscript II (Invitrogen) and serial dilutions of synthesized
cDNA were used for following PCR ampliﬁcation. The primers for
c-Myc were 50-AGACACCGCCCACCACCAGC-30 (forward) and
50-GCACCTCTTGAGGACCAGTG-30 (reverse). Glyceraldehyde-3-
phosphate dehydrogenase speciﬁc primers used for internal con-trol were 50-CCATCACCATCTTCCAGGAG-30 (forward) and 50-
CCTGCTTCACCACCTTCTTG-30 (reverse). Quantitative real-time
PCR (qRT-PCR) was performed using SYBR premix Ex Taq II (TaKa-
Ra) and the iCycler real-time PCR detection System (Bio-Rad). The
primers for qRT-PCR were as follows: 50-GAGAACATGAAGGTAG-
CAC-30 (forward) and 50-CTTGCTTGTAGTCAGGATG-30 (reverse) for
c-GCSH; 50-CTGTGCTGCGAAGTGGAAACCAT (forward) and 50-
TTCATGGCCAGCGGGAAGACCTC (reverse) for cyclin D1; 50-GAT-
GACCGGGTTTACCCAAACTC (forward) and 50-GTGTCGCCATA-
TACCGGTCAAAG (reverse) for cyclin E.
2.4. Reporter assay
HEK293T cells were transfected with 50 ng of reporter plasmid
and 0.5 ng of pRL-CMV-Renilla plasmid (Promega). After 30 h of
transfection, luciferase assay was performed using Dual luciferase
reporter assay system (Promega) and Veritas microplate lumino-
meter (Turner BioSystems, CA, USA). Fireﬂy luciferase activity
was normalized by Renilla luciferase activity.
2.5. siRNA transfection
Stealth siRNA duplex oligonucleotides targeting c-Myc (si-Myc;
50-UUC UUG CUC CUC AGA GUC GCU G-30), NEMO (si-NEMO; 50-
UUG GCU CUU CCA GAG GUG CCU AUU C-30) and scrambled con-
trol siRNA (sc-RNA) were purchased from Invitrogen. Cells were
transfected with siRNA oligonucleotides using Oligofectamine
transfection reagent (Invitrogen) according to the manufacture’s
protocol.3. Results
3.1. NEMO induces upregulation of c-Myc protein abundance
To study the possible involvement of the upstream effectors of
NF-jB pathway in the regulation of c-Myc expression, the protein
level of c-Myc was determined after ectopic overexpression of each
subunit of IKK complex. Unexpectedly, overexpression of HA-
NEMO in HEK293T cells resulted in signiﬁcant increase of endoge-
nous c-Myc protein level in a dose-dependent manner (Fig. 1A). In
contrast, neither HA-IKKa nor HA-IKKb caused any change in c-
Myc protein level. However, co-transfection of HA-IKKa or HA-
IKKb completely blocked the effect of NEMO on increasing c-Myc
abundance. These observations suggest that NEMO increases c-
Myc protein through a mechanism that does not involve kinase
activity of IKK complex. Furthermore, the blockage of NEMO-med-
iated c-Myc increase by HA-IKKa/b co-expression strongly sug-
gests that NEMO cannot act to upregulate c-Myc once NEMO
level is balanced with IKKa/b.
Immunoﬂuorescence staining was also carried out to conﬁrm
the effect of HA-NEMO on c-Myc increase (Fig. 1B). When HEK293T
cells were transfected with HA-NEMO expression vector, c-Myc
staining was highly enhanced in the nuclei of cells overexpressing
HA-NEMO. To test whether NEMO-mediated c-Myc protein upreg-
ulation is cell line-speciﬁc or not, we examined the effect of NEMO
in two other human cancer cell lines, H460 and SW480. Immuno-
ﬂuorescence staining and Western blot analysis clearly show that
c-Myc protein was highly upregulated by overexpression of HA-
NEMO in these cell lines (Fig. 1C), suggesting that the effect of
NEMO on c-Myc upregulation is not a cell line-speciﬁc event.
3.2. Upregulation of c-Myc by NEMO is through protein stabilization
To determine whether NEMO-mediated c-Myc increase
involves transcriptional activation, we examined the effect of
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Fig. 1. Upregulation of c-Myc protein abundance by NEMO. (A) Upregulation of endogenous c-Myc protein by ectopic expression of NEMO in dose-dependent manner and its
reversal by co-expression of IKKa or IKKb. HEK293T cells were transfected with the expression plasmids of HA-IKKa, HA-IKKb, or HA-NEMO at different doses. (B)
Immunoﬂuorescence staining reveals high accumulation of endogenous c-Myc in NEMO overexpressing cells. HEK293T cells were transfected with HA-NEMO expression
vector, and immunostained for endogenous c-Myc and HA-NEMO. (C) Overexpression of NEMO induces c-Myc upregulation also in H460 and SW480 cells. Both cells were
transfected with control or HA-NEMO expression vector for 24 h and immunostained (upper panel), or cell lysates were prepared and subjected to Western blot analysis
(lower panel).
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level of ectopically expressed c-Myc was also increased by HA-
NEMO co-expression (Fig. 2A, left). The mRNA level of c-Myc was
not changed by HA-NEMO overexpression, while c-Myc protein
was highly elevated (Fig. 2A, right), suggesting that NEMO-medi-
ated c-Myc increase does not involve transcriptional induction.
Max protein, an obligate heterodimerization partner of c-Myc
[19], was not affected by HA-NEMO overexpression, indicating
the speciﬁc effect of NEMO on c-Myc. Reporter assay using c-Myc
promoter-luciferase fusion construct showed that HA-NEMO
transfection did not activate c-Myc promoter, but rather slightly
inhibited c-Myc promoter activity (Fig. 2B). This result further sup-
ports the possibility that c-Myc upregulation by NEMO is a tran-
scription-independent event. Since c-Myc protein turnover is
very fast, we then tested whether NEMO overexpression affects
protein stability of c-Myc. We determined c-Myc protein level
remaining at intervals after the treatment of cycloheximide
(CHX), which is an inhibitor of new protein synthesis. c-Myc level
decreased rapidly in the control cells as expected after CHX treat-
ment. However, c-Myc level remained unchanged upon the sameCHX treatment in HA-NEMO-transfected cells (Fig. 2C), indicating
that NEMO stabilized c-Myc protein. We next examined whether
downregulation of NEMO affects the protein stability of c-Myc.
When NEMO expression was downregulated by transfection of
speciﬁc siRNA, the stability of c-Myc protein was reduced (Fig. 2D).
Since c-Myc protein is regulated mainly through the control of
its fast turnover via ubiquitin-dependent proteasome pathway
[20], we tested the effect of NEMO on ubiquitination of c-Myc.
Overexpression of HA-NEMO caused a signiﬁcant decrease in the
amount of ubiquitinated c-Myc, while high level of ubiquitinated
c-Myc was detected in the absence of HA-NEMO transfection
(Fig. 2E). Taken together, these results demonstrate that NEMO in-
duces c-Myc protein accumulation by enhancing protein stability.
3.3. Nuclear NEMO stabilizes c-Myc protein by direct interaction
NEMO is a nucleocytoplasmic shuttling protein [13], and c-Myc
protein upregulated by NEMO overexpression was accumulated
exclusively in the nucleus (Fig. 1B and C). To examine whether
NEMO acts in the nucleus to increase c-Myc protein, we used
HA-NEMO:
c-Myc
α-tubulin
HA-NEMO
- +
FLAG-c-Myc: ++
0
20
40
60
80
100
c-Myc-Luc
R
el
at
iv
e 
Lu
c 
ac
tiv
ity
 (%
)
NEMO (ng): 0 25 100 250
Western
blot
RT-PCR
HA-NEMO:
c-Myc
Max
α-tubulin
GAPDH
HA-NEMO
c-Myc
- +
c-Myc
α-tubulin
CHX (h): 0 0.5 2 0 0.5 2
Control HA-NEMO
HEK293T
H460
CHX (min):
c-Myc
β-actin
NEMO
Sc si-NEMOsiRNA:
0 20 40 60 0 20 40 60
c-Myc
β-actin
NEMO
HA-ubiquitin:
HA-NEMO:
WB: NEMO
ubiquitin-Myc
IP: FLAG
WB: ubiquitin
-
-
IgG heavy chain
IP: FLAG
WB: c-Myc
+ +
+-
+
-
FLAG-c-Myc: - +- +
Fig. 2. NEMO induces c-Myc protein increase by enhancing protein stability. (A) c-Myc upregulation by NEMO is not through increased mRNA expression. Ectopic expression
of c-Myc is also increased by NEMO (left panel). HEK293T cells were transfected with c-Myc expression vector in combination with control or HA-NEMO expression vector.
NEMO overexpression does not induce c-Myc mRNA expression (right panel). Cell lysate and RNA were prepared from HEK293T cells transfected with control or HA-NEMO
expression vector. c-Myc mRNA level was determined by RT-PCR. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the control for RNA loading. Western
blots conﬁrming that c-Myc protein was increased by NEMO in the same experimental set are also shown (right above). (B) NEMO does not activate the transcription from c-
Myc promoter. HEK293T cells were transfected with c-Myc promoter-luciferase reporter together with the indicated amounts of HA-NEMO expression vector. pRL-TK-Renilla
was used as a normalizer for transfection efﬁciency. (C) c-Myc protein is stabilized by NEMO overexpression. HEK293T cells transfected with control or HA-NEMO expression
vector were treated with CHX (30 lM) for indicated times, and endogenous c-Myc protein level was determined. (D) Knock-down of NEMO decreases protein stability of c-
Myc. Cells were transfected with the control or NEMO-speciﬁc siRNA, and treated with CHX. (E) NEMO overexpression prevents ubiquitination of c-Myc protein. HEK293T
cells transfected as indicated were treated with MG-132 (20 nM) for 3 h, then immunoprecipitation and subsequent Western blot analysis were performed using anti-c-Myc
and anti-ubiquitin antibody, respectively.
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clear export, which was previously reported to induce accumula-
tion of NEMO in the nucleus [13]. LMB treatment induced
nuclear accumulation of NEMO in H460 cells but not in SW480
cells (Fig. 3A). Interestingly, c-Myc staining was enhanced after
LMB treatment only in H460 cells, but reduced in SW480 cells
(Fig. 3A). Western blot analysis conﬁrmed the effect of LMB on c-
Myc protein level in these cells (Fig. 3B). The association between
the nuclear accumulation of NEMO and the increase of c-Myc pro-
tein supports the possibility that nuclear NEMO mediates c-Myc
stabilization in the nucleus, and led us to examine whether c-
Myc is colocalized with nuclear NEMO. When HA-NEMO was over-
expressed in HEK293T, HA-NEMOwas distributed both in the cyto-
plasm and nucleus. Nuclear HA-NEMO was highly conﬁned to
certain discrete nuclear regions, and the upregulated endogenous
c-Myc protein was highly colocalized with nuclear NEMO(Fig. 3C). We then tested whether NEMO and c-Myc interact with
each other by co-immunoprecipitation experiment. Endogenous
c-Myc protein was readily co-immunoprecipitated with NEMO,
indicating their interaction (Fig. 3D). These observations strongly
suggest that NEMO stabilizes c-Myc protein in the nucleus through
a direct interaction.
3.4. NEMO induces phosphorylation at Thr-58 and Ser-62 of c-Myc
It has been well demonstrated that a sequential phosphoryla-
tion at Ser62 and Thr58 of c-Myc is important in controlling its sta-
bility [5]. Thus, we examined whether NEMO affects the
phosphorylation status of c-Myc at these amino acid residues.
NEMO overexpression augmented phosphorylation at Ser62 and
more signiﬁcantly at Thr58 (Fig. 4A). This result was unexpected,
because phosphorylation at Thr58 induces a series of events
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Fig. 3. c-Myc stabilization is mediated by direct interaction between c-Myc and NEMO in the nucleus. (A) Coincidence of c-Myc protein upregulation and the accumulation of
NEMO in the nucleus after LMB treatment. Both cells were treated with LMB (10 ng/ml) for 2 h and immunostained for endogenous c-Myc or NEMO. (B) Western blot analysis
showing differential increase of c-Myc protein by LMB treatment between H460 and SW480. (C) Colocalization of overexpressed NEMO and the upregulated c-Myc in the
nucleus. Transfection and staining procedure were the same as described in Fig. 1B, and two typical enlarged images are shown to reveal colocalization. (D) Co-
immunoprecipitation assay showing the interaction between c-Myc and NEMO. HEK293T cells were transfected with HA-NEMO expression vector, then immunoprecipitation
and subsequent Western blot analysis were performed using anti-HA antibody and anti-c-Myc antibody, respectively.
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tion at Thr58 is the recognition of c-Myc by Fbw7, a subunit of E3
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B.-Y. Kim et al. / FEBS Letters 584 (2010) 4524–4530 4529mutant was also signiﬁcantly blocked by NEMO (Fig. 4B), suggest-
ing that NEMO might stabilize c-Myc by interfering with the inter-
action between c-Myc and Fbw7. We therefore examined the effect
of NEMO on the interaction of c-Myc with Fbw7. Unexpectedly, the
interaction between c-Myc and Fbw7 was not inhibited but rather
enhanced by NEMO (Fig. 4C). Considering that NEMO stabilized c-
Myc by reducing ubiquitination (Fig. 2E), this result suggests that
NEMO inhibits the ubiquitinating activity of Fbw7, but not the abil-
ity to interact with c-Myc.
3.5. NEMO enhances the expression of c-Myc target genes
To evaluate the effect of NEMO-induced phosphorylation and
concomitant stabilization of c-Myc on its transcriptional activity,
we carried out reporter assay using 4E box-luciferase reporter.
Co-transfection of NEMO enhanced transcriptional induction from
E box (Fig. 5A), suggesting that NEMO-induced phosphorylation
and stabilization of c-Myc serves as another mechanism to regulate
the transcriptional activity of c-Myc. Next, we examined whether
NEMO affects expression of several selected c-Myc targets. As
shown in Fig. 5B, NEMO overexpression enhanced the expression
of cyclin D1, cyclin E and heavy chain of c-GCSH. In contrast,
knock-down of NEMO by siRNA transfection led to reduction in
the expression of these selected c-Myc target proteins. We then
carried out qRT-PCR to determine mRNA of these target genes.
mRNA levels of c-GCSH, cyclin D1 and cyclin E were also upregu-
lated by NEMO overexpression (Fig. 5C), suggesting that NEMO
overexpression induces the expression of these c-Myc targets by
enhancing the transcriptional activity of c-Myc.
4. Discussion
Accumulated evidences indicate that the regulation of c-Myc
protein turnover through ubiquitin-proteasome pathway is the
major mechanism controlling the function of c-Myc [20]. Fbw7induces ubiquitination of c-Myc in a phosphorylation-dependent
manner, leading to its proteasomal degradation. The importance
of c-Myc phosphorylation at Thr58 in its interaction with Fbw7,
ubiquitination and subsequent degradation has been well estab-
lished [4,20]. Since NEMO enhanced the stability of c-Myc by
reducing ubiquitination level, we expected that both Thr58 phos-
phorylation and c-Myc interaction with Fbw7 would be reduced
by NEMO overexpression. However, our results clearly showed
that both Thr58 phosphorylation and c-Myc/Fbw7 interaction
were increased by NEMO overexpression. This suggests that NEMO
inhibits ubiquitinating activity of Fbw7 without blocking the inter-
action of Fbw7 with Thr58-phoshorylated c-Myc. Thus, the last
step of growth signal-regulated serial phosphorylation and ubiqui-
tination pathway is the target of NEMO action for stabilizing c-
Myc. Why c-Myc phosphorylation at Thr58, which is required for
Fbw7-mediated ubiquitination and thus supposed to lower c-
Myc stability, is increased during NEMO-mediated c-Myc stabiliza-
tion remains to be answered. Besides promotion of ubiquitination
by Fbw7, c-Myc phosphorylation at Thr58 may exert other un-
known functions required for the unique action of NEMO.
Compared to its classical role as an essential scaffold protein for
the activation of IKK complex, stabilization of c-Myc is a unique
function of NEMO that has never been reported. Signaling mole-
cules of NF-jB pathway including IKKs were reported to shuttle
constitutively between the cytoplasm and nucleus [21]. Under cer-
tain circumstances, IKKa, -b, and NEMO are localized in different
cellular compartments [12,13,21], which suggests that each sub-
unit may play different roles in different localization. Stabilization
of c-Myc by NEMO thus represents a unique nuclear function of
NEMO, which may play a role under certain circumstances to reg-
ulate c-Myc activity.
Modiﬁcations of NEMO, such as ubiquitination [22], sumoyla-
tion [12], phosphorylation [23] and oligomerization [24], are in-
volved in the activation of IKK complex to stimulate the NF-jB
pathway in response to various stimuli. Whether any of these
4530 B.-Y. Kim et al. / FEBS Letters 584 (2010) 4524–4530modiﬁcations is also involved in c-Myc stabilization is not known.
Since the result in Fig. 1A supports the possibility that IKK-un-
bound NEMO is responsible for c-Myc stabilization in the nucleus,
it is intriguing to note that genotoxic stress-induced NEMO sumoy-
lation induces nuclear translocation of IKK-unbound free NEMO
[12]. Thus, it will be worthwhile to examine whether sumoylation
of NEMO is involved in the stabilization of c-Myc.
We have demonstrated here that direct interaction between c-
Myc and NEMO results in phosphorylation and stabilization of c-
Myc. The interaction between c-Myc and NEMO comprises a new
novel mechanism to regulate c-Myc function, and thus can be
exploited as a targeting point to control c-Myc function. Multitudes
of evidences have suggested a regulatory feedback loop among NF-
jB networks and c-Myc [14–17], which would provide a mecha-
nism to ﬁne-tune c-Myc level. Our results presented here thus fur-
nish such an interactive loop with an additional link between NF-
jB networks and c-Myc, which operates independently of NF-jB
transcriptional activity. In future studies, the biological signiﬁ-
cance of this c-Myc stabilization by NEMO needs to be addressed
in a variety of biological processes where c-Myc is involved.
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